Large real-world dataset finds TCAR compares favourably with CEA for carotid artery disease patients


Mahmoud Malas (San Diego, USA) presented, for the first time, updated results from the TransCarotid Artery Revascularization (TCAR) Surveillance Project at the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM; 12–15 June, National Harbor, USA).

Malas distilled the data highlights for Vascular News, providing “strong evidence” on the safety and effectiveness of TCAR, which showed lower odds of composite in-hospital stroke, death and myocardial infarction compared to carotid endarterectomy (CEA), as well as lower odds of one-year mortality. He said: “TCAR provides a CEA-like neuroprotection by clamping the carotid artery”.

This video is sponsored by Silk Road Medical.



Please enter your comment!
Please enter your name here